#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Discussion and Conclusions
1-1	0-2	4.	_	_	_	_
1-2	3-13	Discussion	abstract	new	_	_
1-3	14-17	and	_	_	_	_
1-4	18-29	Conclusions	abstract	new	_	_

#Text=In this study , we considered the following two major factors that could influence the evolution of the f8/9 landscape phage library in mice : ( 1 ) its multidisperse characteristics as revealed in soft agar electrophoresis and ( 2 ) organ- and tumor-specific targets for phage binding interactions that can arise from organ- or tissue-specific gene expression .
2-1	30-32	In	_	_	_	_
2-2	33-37	this	abstract[3]	new[3]	coref	4-4[36_3]
2-3	38-43	study	abstract[3]	new[3]	_	_
2-4	44-45	,	_	_	_	_
2-5	46-48	we	person	acc	ana	3-1
2-6	49-59	considered	_	_	_	_
2-7	60-63	the	abstract[5]	new[5]	_	_
2-8	64-73	following	abstract[5]	new[5]	_	_
2-9	74-77	two	abstract[5]	new[5]	_	_
2-10	78-83	major	abstract[5]	new[5]	_	_
2-11	84-91	factors	abstract[5]	new[5]	_	_
2-12	92-96	that	_	_	_	_
2-13	97-102	could	_	_	_	_
2-14	103-112	influence	_	_	_	_
2-15	113-116	the	abstract[6]	new[6]	coref	14-8[0_6]
2-16	117-126	evolution	abstract[6]	new[6]	_	_
2-17	127-129	of	abstract[6]	new[6]	_	_
2-18	130-133	the	abstract[6]|abstract[9]	new[6]|new[9]	ana	2-29[0_9]
2-19	134-138	f8/9	abstract[6]|abstract[9]	new[6]|new[9]	_	_
2-20	139-148	landscape	abstract[6]|abstract|abstract[9]	new[6]|new|new[9]	coref	4-21
2-21	149-154	phage	abstract[6]|place|abstract[9]	new[6]|new|new[9]	coref	2-47
2-22	155-162	library	abstract[6]|abstract[9]	new[6]|new[9]	_	_
2-23	163-165	in	abstract[6]|abstract[9]	new[6]|new[9]	_	_
2-24	166-170	mice	abstract[6]|abstract[9]|animal	new[6]|new[9]|new	_	_
2-25	171-172	:	_	_	_	_
2-26	173-174	(	_	_	_	_
2-27	175-176	1	_	_	_	_
2-28	177-178	)	_	_	_	_
2-29	179-182	its	abstract|abstract[13]	giv|new[13]	coref	16-29[183_0]
2-30	183-196	multidisperse	abstract|abstract[13]	new|new[13]	_	_
2-31	197-212	characteristics	abstract[13]	new[13]	_	_
2-32	213-215	as	_	_	_	_
2-33	216-224	revealed	_	_	_	_
2-34	225-227	in	_	_	_	_
2-35	228-232	soft	object[15]	new[15]	_	_
2-36	233-237	agar	place|object[15]	new|new[15]	_	_
2-37	238-253	electrophoresis	object[15]	new[15]	_	_
2-38	254-257	and	object[15]	new[15]	_	_
2-39	258-259	(	object[15]	new[15]	_	_
2-40	260-261	2	object[15]	new[15]	_	_
2-41	262-263	)	object[15]	new[15]	_	_
2-42	264-270	organ-	abstract[16]	new[16]	_	_
2-43	271-274	and	abstract[16]	new[16]	_	_
2-44	275-289	tumor-specific	abstract[16]	new[16]	_	_
2-45	290-297	targets	abstract[16]	new[16]	_	_
2-46	298-301	for	abstract[16]	new[16]	_	_
2-47	302-307	phage	abstract[16]|abstract|abstract[18]	new[16]|giv|new[18]	coref|coref	3-17|3-32[32_18]
2-48	308-315	binding	abstract[16]|abstract[18]	new[16]|new[18]	_	_
2-49	316-328	interactions	abstract[16]|abstract[18]	new[16]|new[18]	_	_
2-50	329-333	that	_	_	_	_
2-51	334-337	can	_	_	_	_
2-52	338-343	arise	_	_	_	_
2-53	344-348	from	_	_	_	_
2-54	349-355	organ-	abstract[20]	new[20]	coref	14-19[161_20]
2-55	356-358	or	abstract[20]	new[20]	_	_
2-56	359-374	tissue-specific	abstract[20]	new[20]	_	_
2-57	375-379	gene	abstract|abstract[20]	new|new[20]	coref	14-20
2-58	380-390	expression	abstract[20]	new[20]	_	_
2-59	391-392	.	_	_	_	_

#Text=We showed that modified p8 proteins displaying a fusion peptide along the length of the filamentous phage particle would create vastly different particles , each containing unique physicochemical features and supporting complex interactions within a defined microenvironment .
3-1	393-395	We	person	giv	ana	4-4
3-2	396-402	showed	_	_	_	_
3-3	403-407	that	_	_	_	_
3-4	408-416	modified	_	_	_	_
3-5	417-419	p8	abstract|substance[23]	new|new[23]	coref	15-15[171_23]
3-6	420-428	proteins	substance[23]	new[23]	_	_
3-7	429-439	displaying	_	_	_	_
3-8	440-441	a	object[25]	new[25]	coref	5-28[67_25]
3-9	442-448	fusion	abstract|object[25]	new|new[25]	coref	4-14
3-10	449-456	peptide	object[25]	new[25]	_	_
3-11	457-462	along	_	_	_	_
3-12	463-466	the	quantity[26]	new[26]	_	_
3-13	467-473	length	quantity[26]	new[26]	_	_
3-14	474-476	of	quantity[26]	new[26]	_	_
3-15	477-480	the	quantity[26]|object[28]	new[26]|new[28]	ana	3-25[0_28]
3-16	481-492	filamentous	quantity[26]|object[28]	new[26]|new[28]	_	_
3-17	493-498	phage	quantity[26]|place|object[28]	new[26]|giv|new[28]	coref	4-33
3-18	499-507	particle	quantity[26]|object[28]	new[26]|new[28]	_	_
3-19	508-513	would	_	_	_	_
3-20	514-520	create	_	_	_	_
3-21	521-527	vastly	object[29]	new[29]	coref	6-20[78_29]
3-22	528-537	different	object[29]	new[29]	_	_
3-23	538-547	particles	object[29]	new[29]	_	_
3-24	548-549	,	_	_	_	_
3-25	550-554	each	object	giv	coref	4-32[49_0]
3-26	555-565	containing	_	_	_	_
3-27	566-572	unique	abstract[31]	new[31]	coref	17-73[205_31]
3-28	573-588	physicochemical	abstract[31]	new[31]	_	_
3-29	589-597	features	abstract[31]	new[31]	_	_
3-30	598-601	and	_	_	_	_
3-31	602-612	supporting	_	_	_	_
3-32	613-620	complex	abstract[32]	giv[32]	coref	20-11[214_32]
3-33	621-633	interactions	abstract[32]	giv[32]	_	_
3-34	634-640	within	abstract[32]	giv[32]	_	_
3-35	641-642	a	abstract[32]|abstract[33]	giv[32]|new[33]	coref	6-11[74_33]
3-36	643-650	defined	abstract[32]|abstract[33]	giv[32]|new[33]	_	_
3-37	651-667	microenvironment	abstract[32]|abstract[33]	giv[32]|new[33]	_	_
3-38	668-669	.	_	_	_	_

#Text=As reflected in our in vitro migration study , the presence of random fusion peptides with charged amino acids in landscape phages results in significant changes in the ionization state of the phage particle leading to differences in surface charge and their subsequent ability to migrate through an agarose gel , demonstrated previously with isolated clones .
4-1	670-672	As	_	_	_	_
4-2	673-682	reflected	_	_	_	_
4-3	683-685	in	_	_	_	_
4-4	686-689	our	person|abstract[36]	giv|giv[36]	coref|ana	7-2[86_36]|8-20
4-5	690-692	in	abstract[36]	giv[36]	_	_
4-6	693-698	vitro	abstract[36]	giv[36]	_	_
4-7	699-708	migration	abstract|abstract[36]	new|giv[36]	_	_
4-8	709-714	study	abstract[36]	giv[36]	_	_
4-9	715-716	,	_	_	_	_
4-10	717-720	the	abstract[37]	new[37]	_	_
4-11	721-729	presence	abstract[37]	new[37]	_	_
4-12	730-732	of	abstract[37]	new[37]	_	_
4-13	733-739	random	abstract[37]|substance[39]	new[37]|new[39]	_	_
4-14	740-746	fusion	abstract[37]|abstract|substance[39]	new[37]|giv|new[39]	coref	5-30
4-15	747-755	peptides	abstract[37]|substance[39]	new[37]|new[39]	_	_
4-16	756-760	with	abstract[37]|substance[39]	new[37]|new[39]	_	_
4-17	761-768	charged	abstract[37]|substance[39]|substance[41]	new[37]|new[39]|new[41]	_	_
4-18	769-774	amino	abstract[37]|substance[39]|object|substance[41]	new[37]|new[39]|new|new[41]	_	_
4-19	775-780	acids	abstract[37]|substance[39]|substance[41]	new[37]|new[39]|new[41]	_	_
4-20	781-783	in	abstract[37]|substance[39]|substance[41]	new[37]|new[39]|new[41]	_	_
4-21	784-793	landscape	abstract[37]|substance[39]|substance[41]|abstract|abstract[44]	new[37]|new[39]|new[41]|giv|new[44]	coref	5-7
4-22	794-800	phages	abstract[37]|substance[39]|substance[41]|object|abstract[44]	new[37]|new[39]|new[41]|new|new[44]	coref	5-7[60_0]
4-23	801-808	results	abstract[37]|substance[39]|substance[41]|abstract[44]	new[37]|new[39]|new[41]|new[44]	_	_
4-24	809-811	in	abstract[37]|substance[39]|substance[41]|abstract[44]	new[37]|new[39]|new[41]|new[44]	_	_
4-25	812-823	significant	abstract[37]|substance[39]|substance[41]|abstract[44]|abstract[45]	new[37]|new[39]|new[41]|new[44]|new[45]	coref	6-6[71_45]
4-26	824-831	changes	abstract[37]|substance[39]|substance[41]|abstract[44]|abstract[45]	new[37]|new[39]|new[41]|new[44]|new[45]	_	_
4-27	832-834	in	abstract[37]|substance[39]|substance[41]|abstract[44]|abstract[45]	new[37]|new[39]|new[41]|new[44]|new[45]	_	_
4-28	835-838	the	abstract[37]|substance[39]|substance[41]|abstract[44]|abstract[45]|abstract[47]	new[37]|new[39]|new[41]|new[44]|new[45]|new[47]	_	_
4-29	839-849	ionization	abstract[37]|substance[39]|substance[41]|abstract[44]|abstract[45]|abstract|abstract[47]	new[37]|new[39]|new[41]|new[44]|new[45]|new|new[47]	_	_
4-30	850-855	state	abstract[37]|substance[39]|substance[41]|abstract[44]|abstract[45]|abstract[47]	new[37]|new[39]|new[41]|new[44]|new[45]|new[47]	_	_
4-31	856-858	of	abstract[37]|substance[39]|substance[41]|abstract[44]|abstract[45]|abstract[47]	new[37]|new[39]|new[41]|new[44]|new[45]|new[47]	_	_
4-32	859-862	the	abstract[37]|substance[39]|substance[41]|abstract[44]|abstract[45]|abstract[47]|object[49]	new[37]|new[39]|new[41]|new[44]|new[45]|new[47]|giv[49]	coref	5-39[69_49]
4-33	863-868	phage	abstract[37]|substance[39]|substance[41]|abstract[44]|abstract[45]|abstract[47]|place|object[49]	new[37]|new[39]|new[41]|new[44]|new[45]|new[47]|giv|giv[49]	coref	6-21
4-34	869-877	particle	abstract[37]|substance[39]|substance[41]|abstract[44]|abstract[45]|abstract[47]|object[49]	new[37]|new[39]|new[41]|new[44]|new[45]|new[47]|giv[49]	_	_
4-35	878-885	leading	_	_	_	_
4-36	886-888	to	_	_	_	_
4-37	889-900	differences	abstract[50]	new[50]	_	_
4-38	901-903	in	abstract[50]	new[50]	_	_
4-39	904-911	surface	abstract[50]|place|abstract[52]|abstract[53]	new[50]|new|new[52]|new[53]	coref|coref	6-17|6-16[76_52]
4-40	912-918	charge	abstract[50]|abstract[52]|abstract[53]	new[50]|new[52]|new[53]	_	_
4-41	919-922	and	abstract[50]|abstract[53]	new[50]|new[53]	_	_
4-42	923-928	their	abstract[50]|abstract[53]|abstract[54]	new[50]|new[53]|new[54]	coref	5-25[65_54]
4-43	929-939	subsequent	abstract[50]|abstract[53]|abstract[54]	new[50]|new[53]|new[54]	_	_
4-44	940-947	ability	abstract[50]|abstract[53]|abstract[54]	new[50]|new[53]|new[54]	_	_
4-45	948-950	to	_	_	_	_
4-46	951-958	migrate	_	_	_	_
4-47	959-966	through	_	_	_	_
4-48	967-969	an	object[56]	new[56]	_	_
4-49	970-977	agarose	abstract|object[56]	new|new[56]	_	_
4-50	978-981	gel	object[56]	new[56]	_	_
4-51	982-983	,	_	_	_	_
4-52	984-996	demonstrated	_	_	_	_
4-53	997-1007	previously	_	_	_	_
4-54	1008-1012	with	_	_	_	_
4-55	1013-1021	isolated	object[57]	new[57]	_	_
4-56	1022-1028	clones	object[57]	new[57]	_	_
4-57	1029-1030	.	_	_	_	_

#Text=This unique , emergent feature of landscape phages cannot be translated to p3-type libraries as the occurrence of p3 in only five copies limits the ability of a displayed fusion peptide to significantly change the physicochemical properties of the entire particle .
5-1	1031-1035	This	abstract[58]	new[58]	_	_
5-2	1036-1042	unique	abstract[58]	new[58]	_	_
5-3	1043-1044	,	abstract[58]	new[58]	_	_
5-4	1045-1053	emergent	abstract[58]	new[58]	_	_
5-5	1054-1061	feature	abstract[58]	new[58]	_	_
5-6	1062-1064	of	abstract[58]	new[58]	_	_
5-7	1065-1074	landscape	abstract[58]|abstract|object[60]	new[58]|giv|giv[60]	coref|coref	8-3|14-11[158_60]
5-8	1075-1081	phages	abstract[58]|object[60]	new[58]|giv[60]	_	_
5-9	1082-1088	cannot	_	_	_	_
5-10	1089-1091	be	_	_	_	_
5-11	1092-1102	translated	_	_	_	_
5-12	1103-1105	to	_	_	_	_
5-13	1106-1113	p3-type	place[61]	new[61]	coref	8-3[101_61]
5-14	1114-1123	libraries	place[61]	new[61]	_	_
5-15	1124-1126	as	place[61]	new[61]	_	_
5-16	1127-1130	the	place[61]	new[61]	_	_
5-17	1131-1141	occurrence	place[61]	new[61]	_	_
5-18	1142-1144	of	place[61]	new[61]	_	_
5-19	1145-1147	p3	place[61]|substance	new[61]|new	_	_
5-20	1148-1150	in	_	_	_	_
5-21	1151-1155	only	quantity[63]|abstract[64]	new[63]|new[64]	_	_
5-22	1156-1160	five	quantity[63]|abstract[64]	new[63]|new[64]	_	_
5-23	1161-1167	copies	quantity[63]|abstract[64]	new[63]|new[64]	_	_
5-24	1168-1174	limits	abstract[64]	new[64]	_	_
5-25	1175-1178	the	abstract[64]|abstract[65]	new[64]|giv[65]	ana	6-1[0_65]
5-26	1179-1186	ability	abstract[64]|abstract[65]	new[64]|giv[65]	_	_
5-27	1187-1189	of	abstract[64]|abstract[65]	new[64]|giv[65]	_	_
5-28	1190-1191	a	abstract[64]|abstract[65]|object[67]	new[64]|giv[65]|giv[67]	coref	8-7[0_67]
5-29	1192-1201	displayed	abstract[64]|abstract[65]|object[67]	new[64]|giv[65]|giv[67]	_	_
5-30	1202-1208	fusion	abstract[64]|abstract[65]|abstract|object[67]	new[64]|giv[65]|giv|giv[67]	_	_
5-31	1209-1216	peptide	abstract[64]|abstract[65]|object[67]	new[64]|giv[65]|giv[67]	_	_
5-32	1217-1219	to	_	_	_	_
5-33	1220-1233	significantly	_	_	_	_
5-34	1234-1240	change	_	_	_	_
5-35	1241-1244	the	abstract[68]	new[68]	_	_
5-36	1245-1260	physicochemical	abstract[68]	new[68]	_	_
5-37	1261-1271	properties	abstract[68]	new[68]	_	_
5-38	1272-1274	of	abstract[68]	new[68]	_	_
5-39	1275-1278	the	abstract[68]|object[69]	new[68]|giv[69]	coref	7-31[0_69]
5-40	1279-1285	entire	abstract[68]|object[69]	new[68]|giv[69]	_	_
5-41	1286-1294	particle	abstract[68]|object[69]	new[68]|giv[69]	_	_
5-42	1295-1296	.	_	_	_	_

#Text=It can be envisioned that local changes in pH within a tissue microenvironment may modify the surface charge of landscape phage particles , exposing a previously hidden binding epitope or also hiding a previously accessible binding epitope allowing enhanced penetration or retention within a particular microenvironment .
6-1	1297-1299	It	abstract	giv	_	_
6-2	1300-1303	can	_	_	_	_
6-3	1304-1306	be	_	_	_	_
6-4	1307-1317	envisioned	_	_	_	_
6-5	1318-1322	that	_	_	_	_
6-6	1323-1328	local	abstract[71]	giv[71]	_	_
6-7	1329-1336	changes	abstract[71]	giv[71]	_	_
6-8	1337-1339	in	abstract[71]	giv[71]	_	_
6-9	1340-1342	pH	abstract[71]|abstract[72]	giv[71]|new[72]	_	_
6-10	1343-1349	within	abstract[71]|abstract[72]	giv[71]|new[72]	_	_
6-11	1350-1351	a	abstract[71]|abstract[72]|abstract[74]	giv[71]|new[72]|giv[74]	coref	6-44[85_74]
6-12	1352-1358	tissue	abstract[71]|abstract[72]|object|abstract[74]	giv[71]|new[72]|new|giv[74]	coref	9-10
6-13	1359-1375	microenvironment	abstract[71]|abstract[72]|abstract[74]	giv[71]|new[72]|giv[74]	_	_
6-14	1376-1379	may	_	_	_	_
6-15	1380-1386	modify	_	_	_	_
6-16	1387-1390	the	abstract[76]	giv[76]	coref	7-19[91_76]
6-17	1391-1398	surface	place|abstract[76]	giv|giv[76]	coref	7-22
6-18	1399-1405	charge	abstract[76]	giv[76]	_	_
6-19	1406-1408	of	abstract[76]	giv[76]	_	_
6-20	1409-1418	landscape	abstract[76]|object[78]	giv[76]|giv[78]	coref	8-25[110_78]
6-21	1419-1424	phage	abstract[76]|place|object[78]	giv[76]|giv|giv[78]	coref	8-4
6-22	1425-1434	particles	abstract[76]|object[78]	giv[76]|giv[78]	_	_
6-23	1435-1436	,	_	_	_	_
6-24	1437-1445	exposing	_	_	_	_
6-25	1446-1447	a	object[80]	new[80]	coref	6-33[82_80]
6-26	1448-1458	previously	object[80]	new[80]	_	_
6-27	1459-1465	hidden	object[80]	new[80]	_	_
6-28	1466-1473	binding	object|object[80]	new|new[80]	coref	6-36
6-29	1474-1481	epitope	object[80]	new[80]	_	_
6-30	1482-1484	or	_	_	_	_
6-31	1485-1489	also	_	_	_	_
6-32	1490-1496	hiding	_	_	_	_
6-33	1497-1498	a	object[82]	giv[82]	_	_
6-34	1499-1509	previously	object[82]	giv[82]	_	_
6-35	1510-1520	accessible	object[82]	giv[82]	_	_
6-36	1521-1528	binding	object|object[82]	giv|giv[82]	_	_
6-37	1529-1536	epitope	object[82]	giv[82]	_	_
6-38	1537-1545	allowing	_	_	_	_
6-39	1546-1554	enhanced	abstract[83]	new[83]	_	_
6-40	1555-1566	penetration	abstract[83]	new[83]	_	_
6-41	1567-1569	or	_	_	_	_
6-42	1570-1579	retention	abstract[84]	new[84]	_	_
6-43	1580-1586	within	abstract[84]	new[84]	_	_
6-44	1587-1588	a	abstract[84]|abstract[85]	new[84]|giv[85]	ana	7-12[0_85]
6-45	1589-1599	particular	abstract[84]|abstract[85]	new[84]|giv[85]	_	_
6-46	1600-1616	microenvironment	abstract[84]|abstract[85]	new[84]|giv[85]	_	_
6-47	1617-1618	.	_	_	_	_

#Text=Following an extensive meta-analysis study of nanoparticle biocompatibility in vivo , it was concluded that functional nanocarriers had a slightly negative surface charge , moderate to high solubility , and particle sizes in the range of ~100 – 200 nm in diameter .
7-1	1619-1628	Following	_	_	_	_
7-2	1629-1631	an	abstract[86]	giv[86]	coref	9-2[122_86]
7-3	1632-1641	extensive	abstract[86]	giv[86]	_	_
7-4	1642-1655	meta-analysis	abstract[86]	giv[86]	_	_
7-5	1656-1661	study	abstract[86]	giv[86]	_	_
7-6	1662-1664	of	abstract[86]	giv[86]	_	_
7-7	1665-1677	nanoparticle	abstract[86]|substance[87]	giv[86]|new[87]	_	_
7-8	1678-1694	biocompatibility	abstract[86]|substance[87]	giv[86]|new[87]	_	_
7-9	1695-1697	in	abstract[86]|substance[87]	giv[86]|new[87]	_	_
7-10	1698-1702	vivo	abstract[86]|substance[87]	giv[86]|new[87]	_	_
7-11	1703-1704	,	_	_	_	_
7-12	1705-1707	it	abstract	giv	coref	8-43[116_0]
7-13	1708-1711	was	_	_	_	_
7-14	1712-1721	concluded	_	_	_	_
7-15	1722-1726	that	_	_	_	_
7-16	1727-1737	functional	object[89]	new[89]	_	_
7-17	1738-1750	nanocarriers	object[89]	new[89]	_	_
7-18	1751-1754	had	_	_	_	_
7-19	1755-1756	a	abstract[91]	giv[91]	_	_
7-20	1757-1765	slightly	abstract[91]	giv[91]	_	_
7-21	1766-1774	negative	abstract[91]	giv[91]	_	_
7-22	1775-1782	surface	place|abstract[91]	giv|giv[91]	coref	8-14
7-23	1783-1789	charge	abstract[91]	giv[91]	_	_
7-24	1790-1791	,	_	_	_	_
7-25	1792-1800	moderate	_	_	_	_
7-26	1801-1803	to	_	_	_	_
7-27	1804-1808	high	substance[92]	new[92]	_	_
7-28	1809-1819	solubility	substance[92]	new[92]	_	_
7-29	1820-1821	,	_	_	_	_
7-30	1822-1825	and	_	_	_	_
7-31	1826-1834	particle	object|quantity[94]	giv|new[94]	coref	8-52
7-32	1835-1840	sizes	quantity[94]	new[94]	_	_
7-33	1841-1843	in	quantity[94]	new[94]	_	_
7-34	1844-1847	the	quantity[94]|abstract[95]	new[94]|new[95]	_	_
7-35	1848-1853	range	quantity[94]|abstract[95]	new[94]|new[95]	_	_
7-36	1854-1856	of	quantity[94]|abstract[95]	new[94]|new[95]	_	_
7-37	1857-1861	~100	quantity[94]|abstract[95]|abstract[96]	new[94]|new[95]|new[96]	_	_
7-38	1862-1863	–	quantity[94]|abstract[95]|abstract[96]	new[94]|new[95]|new[96]	_	_
7-39	1864-1867	200	quantity[94]|abstract[95]|abstract[96]|quantity[97]	new[94]|new[95]|new[96]|new[97]	_	_
7-40	1868-1870	nm	quantity[94]|abstract[95]|abstract[96]|quantity[97]	new[94]|new[95]|new[96]|new[97]	_	_
7-41	1871-1873	in	quantity[94]|abstract[95]|abstract[96]|quantity[97]	new[94]|new[95]|new[96]|new[97]	_	_
7-42	1874-1882	diameter	quantity[94]|abstract[95]|abstract[96]|quantity[97]|abstract	new[94]|new[95]|new[96]|new[97]|new	_	_
7-43	1883-1884	.	_	_	_	_

#Text=Given that landscape phage libraries display peptide fusions that can dramatically alter the surface profile of the phage , we hypothesized that libraries of phage particles represent ideal nanoparticle systems to test the effects of a displayed peptide on tissue-selective accumulation within the local microenvironment while maintaining other critical parameters like particle size and shape .
8-1	1885-1890	Given	_	_	_	_
8-2	1891-1895	that	_	_	_	_
8-3	1896-1905	landscape	abstract|place[101]	giv|giv[101]	coref|coref	8-23[108_101]|14-11
8-4	1906-1911	phage	abstract|place[101]	giv|giv[101]	coref	8-17[106_0]
8-5	1912-1921	libraries	place[101]	giv[101]	_	_
8-6	1922-1929	display	_	_	_	_
8-7	1930-1937	peptide	object|abstract[103]	giv|new[103]	coref	8-36[114_0]
8-8	1938-1945	fusions	abstract[103]	new[103]	_	_
8-9	1946-1950	that	_	_	_	_
8-10	1951-1954	can	_	_	_	_
8-11	1955-1967	dramatically	_	_	_	_
8-12	1968-1973	alter	_	_	_	_
8-13	1974-1977	the	abstract[105]	new[105]	_	_
8-14	1978-1985	surface	place|abstract[105]	giv|new[105]	_	_
8-15	1986-1993	profile	abstract[105]	new[105]	_	_
8-16	1994-1996	of	abstract[105]	new[105]	_	_
8-17	1997-2000	the	abstract[105]|place[106]	new[105]|giv[106]	coref	8-25[0_106]
8-18	2001-2006	phage	abstract[105]|place[106]	new[105]|giv[106]	_	_
8-19	2007-2008	,	_	_	_	_
8-20	2009-2011	we	person	giv	ana	9-2
8-21	2012-2024	hypothesized	_	_	_	_
8-22	2025-2029	that	_	_	_	_
8-23	2030-2039	libraries	place[108]	giv[108]	coref	9-16[127_108]
8-24	2040-2042	of	place[108]	giv[108]	_	_
8-25	2043-2048	phage	place[108]|place|object[110]	giv[108]|giv|giv[110]	coref	16-32
8-26	2049-2058	particles	place[108]|object[110]	giv[108]|giv[110]	_	_
8-27	2059-2068	represent	_	_	_	_
8-28	2069-2074	ideal	abstract[112]	new[112]	_	_
8-29	2075-2087	nanoparticle	quantity|abstract[112]	new|new[112]	_	_
8-30	2088-2095	systems	abstract[112]	new[112]	_	_
8-31	2096-2098	to	_	_	_	_
8-32	2099-2103	test	_	_	_	_
8-33	2104-2107	the	abstract[113]	new[113]	_	_
8-34	2108-2115	effects	abstract[113]	new[113]	_	_
8-35	2116-2118	of	abstract[113]	new[113]	_	_
8-36	2119-2120	a	abstract[113]|object[114]	new[113]|giv[114]	coref	13-17[0_114]
8-37	2121-2130	displayed	abstract[113]|object[114]	new[113]|giv[114]	_	_
8-38	2131-2138	peptide	abstract[113]|object[114]	new[113]|giv[114]	_	_
8-39	2139-2141	on	abstract[113]|object[114]	new[113]|giv[114]	_	_
8-40	2142-2158	tissue-selective	abstract[113]|object[114]|abstract[115]	new[113]|giv[114]|new[115]	coref	9-10[126_115]
8-41	2159-2171	accumulation	abstract[113]|object[114]|abstract[115]	new[113]|giv[114]|new[115]	_	_
8-42	2172-2178	within	abstract[113]|object[114]|abstract[115]	new[113]|giv[114]|new[115]	_	_
8-43	2179-2182	the	abstract[113]|object[114]|abstract[115]|abstract[116]	new[113]|giv[114]|new[115]|giv[116]	coref	17-77[206_116]
8-44	2183-2188	local	abstract[113]|object[114]|abstract[115]|abstract[116]	new[113]|giv[114]|new[115]|giv[116]	_	_
8-45	2189-2205	microenvironment	abstract[113]|object[114]|abstract[115]|abstract[116]	new[113]|giv[114]|new[115]|giv[116]	_	_
8-46	2206-2211	while	_	_	_	_
8-47	2212-2223	maintaining	_	_	_	_
8-48	2224-2229	other	abstract[117]	new[117]	_	_
8-49	2230-2238	critical	abstract[117]	new[117]	_	_
8-50	2239-2249	parameters	abstract[117]	new[117]	_	_
8-51	2250-2254	like	abstract[117]	new[117]	_	_
8-52	2255-2263	particle	abstract[117]|object|abstract[119]	new[117]|giv|new[119]	_	_
8-53	2264-2268	size	abstract[117]|abstract[119]	new[117]|new[119]	_	_
8-54	2269-2272	and	abstract[117]	new[117]	_	_
8-55	2273-2278	shape	abstract[117]|abstract	new[117]|new	_	_
8-56	2279-2280	.	_	_	_	_

#Text=In our study , we observed similar trends of tissue accumulation as reported previously for p3-type libraries .
9-1	2281-2283	In	_	_	_	_
9-2	2284-2287	our	person|abstract[122]	giv|giv[122]	ana	9-5
9-3	2288-2293	study	abstract[122]	giv[122]	_	_
9-4	2294-2295	,	_	_	_	_
9-5	2296-2298	we	person	giv	ana	11-1
9-6	2299-2307	observed	_	_	_	_
9-7	2308-2315	similar	abstract[124]	new[124]	_	_
9-8	2316-2322	trends	abstract[124]	new[124]	_	_
9-9	2323-2325	of	abstract[124]	new[124]	_	_
9-10	2326-2332	tissue	abstract[124]|object|abstract[126]	new[124]|giv|giv[126]	coref|coref	10-6[130_0]|13-25[151_126]
9-11	2333-2345	accumulation	abstract[124]|abstract[126]	new[124]|giv[126]	_	_
9-12	2346-2348	as	_	_	_	_
9-13	2349-2357	reported	_	_	_	_
9-14	2358-2368	previously	_	_	_	_
9-15	2369-2372	for	_	_	_	_
9-16	2373-2380	p3-type	place[127]	giv[127]	coref	16-25[180_127]
9-17	2381-2390	libraries	place[127]	giv[127]	_	_
9-18	2391-2392	.	_	_	_	_

#Text=Analysis of 3-mer frequency in each tissue revealed that a significant portion of motifs were shared across all tissues , leading to nonspecific uptake and clearance or had very low occurrences .
10-1	2393-2401	Analysis	abstract[128]	new[128]	_	_
10-2	2402-2404	of	abstract[128]	new[128]	_	_
10-3	2405-2410	3-mer	abstract[128]|abstract[129]	new[128]|new[129]	_	_
10-4	2411-2420	frequency	abstract[128]|abstract[129]	new[128]|new[129]	_	_
10-5	2421-2423	in	abstract[128]|abstract[129]	new[128]|new[129]	_	_
10-6	2424-2428	each	abstract[128]|abstract[129]|object[130]	new[128]|new[129]|giv[130]	coref	13-25[0_130]
10-7	2429-2435	tissue	abstract[128]|abstract[129]|object[130]	new[128]|new[129]|giv[130]	_	_
10-8	2436-2444	revealed	_	_	_	_
10-9	2445-2449	that	_	_	_	_
10-10	2450-2451	a	abstract[131]	new[131]	_	_
10-11	2452-2463	significant	abstract[131]	new[131]	_	_
10-12	2464-2471	portion	abstract[131]	new[131]	_	_
10-13	2472-2474	of	abstract[131]	new[131]	_	_
10-14	2475-2481	motifs	abstract[131]|abstract	new[131]|new	coref	11-9
10-15	2482-2486	were	_	_	_	_
10-16	2487-2493	shared	_	_	_	_
10-17	2494-2500	across	_	_	_	_
10-18	2501-2504	all	abstract[133]	new[133]	coref	17-24[192_133]
10-19	2505-2512	tissues	abstract[133]	new[133]	_	_
10-20	2513-2514	,	_	_	_	_
10-21	2515-2522	leading	_	_	_	_
10-22	2523-2525	to	_	_	_	_
10-23	2526-2537	nonspecific	abstract[134]	new[134]	_	_
10-24	2538-2544	uptake	abstract[134]	new[134]	_	_
10-25	2545-2548	and	_	_	_	_
10-26	2549-2558	clearance	abstract	new	_	_
10-27	2559-2561	or	_	_	_	_
10-28	2562-2565	had	_	_	_	_
10-29	2566-2570	very	abstract[136]	new[136]	_	_
10-30	2571-2574	low	abstract[136]	new[136]	_	_
10-31	2575-2586	occurrences	abstract[136]	new[136]	_	_
10-32	2587-2588	.	_	_	_	_

#Text=We were able to identify several families of motifs that were enriched in a tissue-selective manner .
11-1	2589-2591	We	person	giv	ana	13-3
11-2	2592-2596	were	_	_	_	_
11-3	2597-2601	able	_	_	_	_
11-4	2602-2604	to	_	_	_	_
11-5	2605-2613	identify	_	_	_	_
11-6	2614-2621	several	abstract[138]	new[138]	_	_
11-7	2622-2630	families	abstract[138]	new[138]	_	_
11-8	2631-2633	of	abstract[138]	new[138]	_	_
11-9	2634-2640	motifs	abstract[138]|abstract	new[138]|giv	coref	12-3[142_0]
11-10	2641-2645	that	_	_	_	_
11-11	2646-2650	were	_	_	_	_
11-12	2651-2659	enriched	_	_	_	_
11-13	2660-2662	in	_	_	_	_
11-14	2663-2664	a	abstract[140]	new[140]	ana	12-1[141_140]
11-15	2665-2681	tissue-selective	abstract[140]	new[140]	_	_
11-16	2682-2688	manner	abstract[140]	new[140]	_	_
11-17	2689-2690	.	_	_	_	_

#Text=Some of the identified motifs corresponded with previously identified tissue-selective motifs .
12-1	2691-2695	Some	abstract[141]	giv[141]	_	_
12-2	2696-2698	of	abstract[141]	giv[141]	_	_
12-3	2699-2702	the	abstract[141]|abstract[142]	giv[141]|giv[142]	coref	12-8[143_142]
12-4	2703-2713	identified	abstract[141]|abstract[142]	giv[141]|giv[142]	_	_
12-5	2714-2720	motifs	abstract[141]|abstract[142]	giv[141]|giv[142]	_	_
12-6	2721-2733	corresponded	_	_	_	_
12-7	2734-2738	with	_	_	_	_
12-8	2739-2749	previously	abstract[143]	giv[143]	coref	13-5[145_143]
12-9	2750-2760	identified	abstract[143]	giv[143]	_	_
12-10	2761-2777	tissue-selective	abstract[143]	giv[143]	_	_
12-11	2778-2784	motifs	abstract[143]	giv[143]	_	_
12-12	2785-2786	.	_	_	_	_

#Text=However , we identified many motifs that were not reported , suggesting that the type of peptide display will have a significant effect on tissue accumulation or pharmacokinetics .
13-1	2787-2794	However	_	_	_	_
13-2	2795-2796	,	_	_	_	_
13-3	2797-2799	we	person	giv	ana	14-5
13-4	2800-2810	identified	_	_	_	_
13-5	2811-2815	many	abstract[145]	giv[145]	coref	17-15[190_145]
13-6	2816-2822	motifs	abstract[145]	giv[145]	_	_
13-7	2823-2827	that	_	_	_	_
13-8	2828-2832	were	_	_	_	_
13-9	2833-2836	not	_	_	_	_
13-10	2837-2845	reported	_	_	_	_
13-11	2846-2847	,	_	_	_	_
13-12	2848-2858	suggesting	_	_	_	_
13-13	2859-2863	that	_	_	_	_
13-14	2864-2867	the	event[146]	new[146]	_	_
13-15	2868-2872	type	event[146]	new[146]	_	_
13-16	2873-2875	of	event[146]	new[146]	_	_
13-17	2876-2883	peptide	event[146]|object|object[148]	new[146]|giv|new[148]	coref	16-25
13-18	2884-2891	display	event[146]|object[148]	new[146]|new[148]	_	_
13-19	2892-2896	will	_	_	_	_
13-20	2897-2901	have	_	_	_	_
13-21	2902-2903	a	abstract[149]	new[149]	_	_
13-22	2904-2915	significant	abstract[149]	new[149]	_	_
13-23	2916-2922	effect	abstract[149]	new[149]	_	_
13-24	2923-2925	on	abstract[149]	new[149]	_	_
13-25	2926-2932	tissue	abstract[149]|object|abstract[151]	new[149]|giv|giv[151]	coref|coref	14-29|26-33[259_151]
13-26	2933-2945	accumulation	abstract[149]|abstract[151]	new[149]|giv[151]	_	_
13-27	2946-2948	or	abstract[149]	new[149]	_	_
13-28	2949-2965	pharmacokinetics	abstract[149]|abstract	new[149]|new	_	_
13-29	2966-2967	.	_	_	_	_

#Text=The underlying hypothesis in our in vivo evolution study of landscape phages is based on the assumption that tissue-specific gene expression provides a context-dependent pathway for development of tissue specificity .
14-1	2968-2971	The	abstract[153]	new[153]	coref	17-4[185_153]
14-2	2972-2982	underlying	abstract[153]	new[153]	_	_
14-3	2983-2993	hypothesis	abstract[153]	new[153]	_	_
14-4	2994-2996	in	abstract[153]	new[153]	_	_
14-5	2997-3000	our	abstract[153]|person|abstract[156]	new[153]|giv|new[156]	ana	17-7
14-6	3001-3003	in	abstract[153]|abstract[156]	new[153]|new[156]	_	_
14-7	3004-3008	vivo	abstract[153]|abstract[156]	new[153]|new[156]	_	_
14-8	3009-3018	evolution	abstract[153]|abstract|abstract[156]	new[153]|giv|new[156]	_	_
14-9	3019-3024	study	abstract[153]|abstract[156]	new[153]|new[156]	_	_
14-10	3025-3027	of	abstract[153]|abstract[156]	new[153]|new[156]	_	_
14-11	3028-3037	landscape	abstract[153]|abstract[156]|abstract|abstract[158]	new[153]|new[156]|giv|giv[158]	coref|coref	16-31|26-36[0_158]
14-12	3038-3044	phages	abstract[153]|abstract[156]|abstract[158]	new[153]|new[156]|giv[158]	_	_
14-13	3045-3047	is	_	_	_	_
14-14	3048-3053	based	_	_	_	_
14-15	3054-3056	on	_	_	_	_
14-16	3057-3060	the	abstract[159]	new[159]	_	_
14-17	3061-3071	assumption	abstract[159]	new[159]	_	_
14-18	3072-3076	that	abstract[159]	new[159]	_	_
14-19	3077-3092	tissue-specific	abstract[159]|abstract[161]	new[159]|giv[161]	coref	15-3[167_161]
14-20	3093-3097	gene	abstract[159]|abstract|abstract[161]	new[159]|giv|giv[161]	coref	15-3
14-21	3098-3108	expression	abstract[159]|abstract[161]	new[159]|giv[161]	_	_
14-22	3109-3117	provides	abstract[159]	new[159]	_	_
14-23	3118-3119	a	abstract[159]|abstract[162]	new[159]|new[162]	_	_
14-24	3120-3137	context-dependent	abstract[159]|abstract[162]	new[159]|new[162]	_	_
14-25	3138-3145	pathway	abstract[159]|abstract[162]	new[159]|new[162]	_	_
14-26	3146-3149	for	abstract[159]|abstract[162]	new[159]|new[162]	_	_
14-27	3150-3161	development	abstract[159]|abstract[162]|event[163]	new[159]|new[162]|new[163]	_	_
14-28	3162-3164	of	abstract[159]|abstract[162]|event[163]	new[159]|new[162]|new[163]	_	_
14-29	3165-3171	tissue	abstract[159]|abstract[162]|event[163]|object|abstract[165]	new[159]|new[162]|new[163]|giv|new[165]	coref	18-16
14-30	3172-3183	specificity	abstract[159]|abstract[162]|event[163]|abstract[165]	new[159]|new[162]|new[163]|new[165]	_	_
14-31	3184-3185	.	_	_	_	_

#Text=These tissue-specific gene expression profiles provide transcriptional and translational control for tissue-specific synthesis of corresponding proteins and their underlying protein-domain networks .
15-1	3186-3191	These	object[168]	new[168]	ana	15-18[0_168]
15-2	3192-3207	tissue-specific	object[168]	new[168]	_	_
15-3	3208-3212	gene	abstract|abstract[167]|object[168]	giv|giv[167]|new[168]	coref|coref	17-65|17-66[0_167]
15-4	3213-3223	expression	abstract[167]|object[168]	giv[167]|new[168]	_	_
15-5	3224-3232	profiles	object[168]	new[168]	_	_
15-6	3233-3240	provide	_	_	_	_
15-7	3241-3256	transcriptional	abstract[169]	new[169]	_	_
15-8	3257-3260	and	abstract[169]	new[169]	_	_
15-9	3261-3274	translational	abstract[169]	new[169]	_	_
15-10	3275-3282	control	abstract[169]	new[169]	_	_
15-11	3283-3286	for	abstract[169]	new[169]	_	_
15-12	3287-3302	tissue-specific	abstract[169]|abstract[170]	new[169]|new[170]	ana	16-1[0_170]
15-13	3303-3312	synthesis	abstract[169]|abstract[170]	new[169]|new[170]	_	_
15-14	3313-3315	of	abstract[169]|abstract[170]	new[169]|new[170]	_	_
15-15	3316-3329	corresponding	abstract[169]|abstract[170]|substance[171]	new[169]|new[170]|giv[171]	_	_
15-16	3330-3338	proteins	abstract[169]|abstract[170]|substance[171]	new[169]|new[170]|giv[171]	_	_
15-17	3339-3342	and	abstract[169]|abstract[170]|substance[171]	new[169]|new[170]|giv[171]	_	_
15-18	3343-3348	their	abstract[169]|abstract[170]|substance[171]|object|abstract[173]	new[169]|new[170]|giv[171]|giv|new[173]	coref|coref	16-7[176_173]|17-64[203_0]
15-19	3349-3359	underlying	abstract[169]|abstract[170]|substance[171]|abstract[173]	new[169]|new[170]|giv[171]|new[173]	_	_
15-20	3360-3374	protein-domain	abstract[169]|abstract[170]|substance[171]|abstract[173]	new[169]|new[170]|giv[171]|new[173]	_	_
15-21	3375-3383	networks	abstract[169]|abstract[170]|substance[171]|abstract[173]	new[169]|new[170]|giv[171]|new[173]	_	_
15-22	3384-3385	.	_	_	_	_

#Text=It was suggested that components of these protein-domain networks could be identified through in vitro or in vivo targeted evolution of EBU/SLiM-harboring phage displayed peptide libraries such as the multivalent landscape phage library used in this project .
16-1	3386-3388	It	abstract	giv	_	_
16-2	3389-3392	was	_	_	_	_
16-3	3393-3402	suggested	_	_	_	_
16-4	3403-3407	that	_	_	_	_
16-5	3408-3418	components	abstract[175]	new[175]	_	_
16-6	3419-3421	of	abstract[175]	new[175]	_	_
16-7	3422-3427	these	abstract[175]|abstract[176]	new[175]|giv[176]	_	_
16-8	3428-3442	protein-domain	abstract[175]|abstract[176]	new[175]|giv[176]	_	_
16-9	3443-3451	networks	abstract[175]|abstract[176]	new[175]|giv[176]	_	_
16-10	3452-3457	could	_	_	_	_
16-11	3458-3460	be	_	_	_	_
16-12	3461-3471	identified	_	_	_	_
16-13	3472-3479	through	_	_	_	_
16-14	3480-3482	in	_	_	_	_
16-15	3483-3488	vitro	_	_	_	_
16-16	3489-3491	or	_	_	_	_
16-17	3492-3494	in	_	_	_	_
16-18	3495-3499	vivo	abstract[177]	new[177]	_	_
16-19	3500-3508	targeted	abstract[177]	new[177]	_	_
16-20	3509-3518	evolution	abstract[177]	new[177]	_	_
16-21	3519-3521	of	abstract[177]	new[177]	_	_
16-22	3522-3540	EBU/SLiM-harboring	abstract[177]|event	new[177]|new	_	_
16-23	3541-3546	phage	abstract[177]	new[177]	_	_
16-24	3547-3556	displayed	_	_	_	_
16-25	3557-3564	peptide	object|place[180]	giv|giv[180]	_	_
16-26	3565-3574	libraries	place[180]	giv[180]	_	_
16-27	3575-3579	such	place[180]	giv[180]	_	_
16-28	3580-3582	as	place[180]	giv[180]	_	_
16-29	3583-3586	the	place[180]|abstract[183]	giv[180]|giv[183]	_	_
16-30	3587-3598	multivalent	place[180]|abstract[183]	giv[180]|giv[183]	_	_
16-31	3599-3608	landscape	place[180]|abstract|abstract[183]	giv[180]|giv|giv[183]	_	_
16-32	3609-3614	phage	place[180]|place|abstract[183]	giv[180]|giv|giv[183]	_	_
16-33	3615-3622	library	place[180]|abstract[183]	giv[180]|giv[183]	_	_
16-34	3623-3627	used	_	_	_	_
16-35	3628-3630	in	_	_	_	_
16-36	3631-3635	this	abstract[184]	new[184]	_	_
16-37	3636-3643	project	abstract[184]	new[184]	_	_
16-38	3644-3645	.	_	_	_	_

#Text=In accordance with this hypothesis , we identified the following three major types of EBU motifs : ( 1 ) motifs common for all tissues ; ( 2 ) motifs specific for organs with functionally related tissues and similar correlated patterns of co-expressed genes ; and ( 3 ) motifs unique to single tissues with unique functions , which may be related to tissue-specific gene expression profiles within the tissues or to specific physical features of the local microenvironment .
17-1	3646-3648	In	_	_	_	_
17-2	3649-3659	accordance	_	_	_	_
17-3	3660-3664	with	_	_	_	_
17-4	3665-3669	this	abstract[185]	giv[185]	_	_
17-5	3670-3680	hypothesis	abstract[185]	giv[185]	_	_
17-6	3681-3682	,	_	_	_	_
17-7	3683-3685	we	person	giv	ana	18-3
17-8	3686-3696	identified	_	_	_	_
17-9	3697-3700	the	place[187]|abstract[188]	new[187]|new[188]	coref|coref	18-15[211_187]|25-7[244_188]
17-10	3701-3710	following	place[187]|abstract[188]	new[187]|new[188]	_	_
17-11	3711-3716	three	place[187]|abstract[188]	new[187]|new[188]	_	_
17-12	3717-3722	major	place[187]|abstract[188]	new[187]|new[188]	_	_
17-13	3723-3728	types	place[187]|abstract[188]	new[187]|new[188]	_	_
17-14	3729-3731	of	place[187]|abstract[188]	new[187]|new[188]	_	_
17-15	3732-3735	EBU	place[187]|abstract[188]|abstract|abstract[190]	new[187]|new[188]|new|giv[190]	coref	17-18[191_190]
17-16	3736-3742	motifs	place[187]|abstract[188]|abstract[190]	new[187]|new[188]|giv[190]	_	_
17-17	3743-3744	:	abstract[188]	new[188]	_	_
17-18	3745-3746	(	abstract[188]|abstract[191]	new[188]|giv[191]	coref	17-30[193_191]
17-19	3747-3748	1	abstract[188]|abstract[191]	new[188]|giv[191]	_	_
17-20	3749-3750	)	abstract[188]|abstract[191]	new[188]|giv[191]	_	_
17-21	3751-3757	motifs	abstract[188]|abstract[191]	new[188]|giv[191]	_	_
17-22	3758-3764	common	abstract[188]|abstract[191]	new[188]|giv[191]	_	_
17-23	3765-3768	for	_	_	_	_
17-24	3769-3772	all	abstract[192]	giv[192]	coref	17-35[195_192]
17-25	3773-3780	tissues	abstract[192]	giv[192]	_	_
17-26	3781-3782	;	abstract[192]	giv[192]	_	_
17-27	3783-3784	(	abstract[192]	giv[192]	_	_
17-28	3785-3786	2	abstract[192]	giv[192]	_	_
17-29	3787-3788	)	abstract[192]	giv[192]	_	_
17-30	3789-3795	motifs	abstract[192]|abstract[193]	giv[192]|giv[193]	coref	17-47[198_193]
17-31	3796-3804	specific	abstract[192]|abstract[193]	giv[192]|giv[193]	_	_
17-32	3805-3808	for	_	_	_	_
17-33	3809-3815	organs	object[194]	new[194]	coref	25-1[241_194]
17-34	3816-3820	with	object[194]	new[194]	_	_
17-35	3821-3833	functionally	object[194]|abstract[195]	new[194]|giv[195]	coref	17-53[199_195]
17-36	3834-3841	related	object[194]|abstract[195]	new[194]|giv[195]	_	_
17-37	3842-3849	tissues	object[194]|abstract[195]	new[194]|giv[195]	_	_
17-38	3850-3853	and	object[194]|abstract[195]	new[194]|giv[195]	_	_
17-39	3854-3861	similar	object[194]|abstract[195]|abstract[196]	new[194]|giv[195]|new[196]	_	_
17-40	3862-3872	correlated	object[194]|abstract[195]|abstract[196]	new[194]|giv[195]|new[196]	_	_
17-41	3873-3881	patterns	object[194]|abstract[195]|abstract[196]	new[194]|giv[195]|new[196]	_	_
17-42	3882-3884	of	object[194]|abstract[195]|abstract[196]	new[194]|giv[195]|new[196]	_	_
17-43	3885-3897	co-expressed	object[194]|abstract[195]|abstract[196]|abstract[197]	new[194]|giv[195]|new[196]|new[197]	coref	20-19[0_197]
17-44	3898-3903	genes	object[194]|abstract[195]|abstract[196]|abstract[197]	new[194]|giv[195]|new[196]|new[197]	_	_
17-45	3904-3905	;	object[194]|abstract[195]|abstract[196]	new[194]|giv[195]|new[196]	_	_
17-46	3906-3909	and	object[194]|abstract[195]|abstract[196]	new[194]|giv[195]|new[196]	_	_
17-47	3910-3911	(	object[194]|abstract[195]|abstract[196]|abstract[198]	new[194]|giv[195]|new[196]|giv[198]	coref	18-9[209_198]
17-48	3912-3913	3	object[194]|abstract[195]|abstract[196]|abstract[198]	new[194]|giv[195]|new[196]|giv[198]	_	_
17-49	3914-3915	)	object[194]|abstract[195]|abstract[196]|abstract[198]	new[194]|giv[195]|new[196]|giv[198]	_	_
17-50	3916-3922	motifs	object[194]|abstract[195]|abstract[196]|abstract[198]	new[194]|giv[195]|new[196]|giv[198]	_	_
17-51	3923-3929	unique	object[194]|abstract[195]|abstract[196]|abstract[198]	new[194]|giv[195]|new[196]|giv[198]	_	_
17-52	3930-3932	to	_	_	_	_
17-53	3933-3939	single	abstract[199]	giv[199]	coref	17-69[204_199]
17-54	3940-3947	tissues	abstract[199]	giv[199]	_	_
17-55	3948-3952	with	abstract[199]	giv[199]	_	_
17-56	3953-3959	unique	abstract[199]|abstract[200]	giv[199]|new[200]	coref	25-17[247_200]
17-57	3960-3969	functions	abstract[199]|abstract[200]	giv[199]|new[200]	_	_
17-58	3970-3971	,	_	_	_	_
17-59	3972-3977	which	_	_	_	_
17-60	3978-3981	may	_	_	_	_
17-61	3982-3984	be	_	_	_	_
17-62	3985-3992	related	_	_	_	_
17-63	3993-3995	to	_	_	_	_
17-64	3996-4011	tissue-specific	object[203]	giv[203]	_	_
17-65	4012-4016	gene	abstract|object[203]	giv|giv[203]	coref	21-15
17-66	4017-4027	expression	abstract|object[203]	giv|giv[203]	coref	21-16
17-67	4028-4036	profiles	object[203]	giv[203]	_	_
17-68	4037-4043	within	object[203]	giv[203]	_	_
17-69	4044-4047	the	object[203]|abstract[204]	giv[203]|giv[204]	coref	21-10[227_204]
17-70	4048-4055	tissues	object[203]|abstract[204]	giv[203]|giv[204]	_	_
17-71	4056-4058	or	_	_	_	_
17-72	4059-4061	to	_	_	_	_
17-73	4062-4070	specific	abstract[205]	giv[205]	_	_
17-74	4071-4079	physical	abstract[205]	giv[205]	_	_
17-75	4080-4088	features	abstract[205]	giv[205]	_	_
17-76	4089-4091	of	abstract[205]	giv[205]	_	_
17-77	4092-4095	the	abstract[205]|abstract[206]	giv[205]|giv[206]	coref	25-12[246_206]
17-78	4096-4101	local	abstract[205]|abstract[206]	giv[205]|giv[206]	_	_
17-79	4102-4118	microenvironment	abstract[205]|abstract[206]	giv[205]|giv[206]	_	_
17-80	4119-4120	.	_	_	_	_

#Text=Here , we demonstrated that the frequencies of several 3-mer motifs are shared across all tissue types (
18-1	4121-4125	Here	_	_	_	_
18-2	4126-4127	,	_	_	_	_
18-3	4128-4130	we	person	giv	ana	26-3
18-4	4131-4143	demonstrated	_	_	_	_
18-5	4144-4148	that	_	_	_	_
18-6	4149-4152	the	abstract[208]	new[208]	_	_
18-7	4153-4164	frequencies	abstract[208]	new[208]	_	_
18-8	4165-4167	of	abstract[208]	new[208]	_	_
18-9	4168-4175	several	abstract[208]|abstract[209]	new[208]|giv[209]	coref	22-8[234_209]
18-10	4176-4181	3-mer	abstract[208]|abstract[209]	new[208]|giv[209]	_	_
18-11	4182-4188	motifs	abstract[208]|abstract[209]	new[208]|giv[209]	_	_
18-12	4189-4192	are	_	_	_	_
18-13	4193-4199	shared	_	_	_	_
18-14	4200-4206	across	_	_	_	_
18-15	4207-4210	all	place[211]	giv[211]	coref	20-25[221_211]
18-16	4211-4217	tissue	object|place[211]	giv|giv[211]	coref	20-26
18-17	4218-4223	types	place[211]	giv[211]	_	_
18-18	4224-4225	(	_	_	_	_

#Text=Figure 5
19-1	4226-4232	Figure	abstract[212]	new[212]	coref	23-1[240_212]
19-2	4233-4234	5	abstract[212]	new[212]	_	_

#Text=A , black arrow ) and can be representative of interactions with protein products of “ housekeeping-like ” genes expressed at constant levels across all tissue types , such as those involved in metabolism .
20-1	4235-4236	A	object[213]	new[213]	_	_
20-2	4237-4238	,	object[213]	new[213]	_	_
20-3	4239-4244	black	object[213]	new[213]	_	_
20-4	4245-4250	arrow	object[213]	new[213]	_	_
20-5	4251-4252	)	_	_	_	_
20-6	4253-4256	and	_	_	_	_
20-7	4257-4260	can	_	_	_	_
20-8	4261-4263	be	_	_	_	_
20-9	4264-4278	representative	_	_	_	_
20-10	4279-4281	of	_	_	_	_
20-11	4282-4294	interactions	abstract[214]	giv[214]	_	_
20-12	4295-4299	with	abstract[214]	giv[214]	_	_
20-13	4300-4307	protein	abstract[214]|substance|abstract[216]	giv[214]|new|new[216]	_	_
20-14	4308-4316	products	abstract[214]|abstract[216]	giv[214]|new[216]	_	_
20-15	4317-4319	of	abstract[214]|abstract[216]	giv[214]|new[216]	_	_
20-16	4320-4321	“	abstract[214]|abstract[216]	giv[214]|new[216]	_	_
20-17	4322-4339	housekeeping-like	abstract[214]|abstract[216]|abstract	giv[214]|new[216]|new	_	_
20-18	4340-4341	”	abstract[214]|abstract[216]	giv[214]|new[216]	_	_
20-19	4342-4347	genes	abstract[214]|abstract[216]|abstract	giv[214]|new[216]|giv	ana	20-31
20-20	4348-4357	expressed	_	_	_	_
20-21	4358-4360	at	_	_	_	_
20-22	4361-4369	constant	abstract[219]	new[219]	_	_
20-23	4370-4376	levels	abstract[219]	new[219]	_	_
20-24	4377-4383	across	abstract[219]	new[219]	_	_
20-25	4384-4387	all	abstract[219]|place[221]	new[219]|giv[221]	coref	25-7[243_221]
20-26	4388-4394	tissue	abstract[219]|object|place[221]	new[219]|giv|giv[221]	_	_
20-27	4395-4400	types	abstract[219]|place[221]	new[219]|giv[221]	_	_
20-28	4401-4402	,	abstract[219]	new[219]	_	_
20-29	4403-4407	such	abstract[219]	new[219]	_	_
20-30	4408-4410	as	abstract[219]	new[219]	_	_
20-31	4411-4416	those	abstract[219]|abstract	new[219]|giv	coref	26-20[256_0]
20-32	4417-4425	involved	_	_	_	_
20-33	4426-4428	in	_	_	_	_
20-34	4429-4439	metabolism	abstract	new	_	_
20-35	4440-4441	.	_	_	_	_

#Text=Similar patterns of motif enrichment could be identified in tissues with functionally-related roles and gene expression patterns .
21-1	4442-4449	Similar	abstract[224]	new[224]	coref	21-15[231_224]
21-2	4450-4458	patterns	abstract[224]	new[224]	_	_
21-3	4459-4461	of	abstract[224]	new[224]	_	_
21-4	4462-4467	motif	abstract[224]|abstract|abstract[226]	new[224]|new|new[226]	ana|coref	22-1[0_226]|26-5
21-5	4468-4478	enrichment	abstract[224]|abstract[226]	new[224]|new[226]	_	_
21-6	4479-4484	could	_	_	_	_
21-7	4485-4487	be	_	_	_	_
21-8	4488-4498	identified	_	_	_	_
21-9	4499-4501	in	_	_	_	_
21-10	4502-4509	tissues	abstract[227]	giv[227]	coref	22-24[239_227]
21-11	4510-4514	with	abstract[227]	giv[227]	_	_
21-12	4515-4535	functionally-related	abstract[227]|abstract[228]	giv[227]|new[228]	_	_
21-13	4536-4541	roles	abstract[227]|abstract[228]	giv[227]|new[228]	_	_
21-14	4542-4545	and	abstract[227]	giv[227]	_	_
21-15	4546-4550	gene	abstract[227]|abstract|abstract[231]	giv[227]|giv|giv[231]	coref	22-10[235_231]
21-16	4551-4561	expression	abstract[227]|abstract|abstract[231]	giv[227]|giv|giv[231]	_	_
21-17	4562-4570	patterns	abstract[227]|abstract[231]	giv[227]|giv[231]	_	_
21-18	4571-4572	.	_	_	_	_

#Text=This can be visualized by enrichment of similar motifs patterns between the liver and spleen with 25 significantly enriched motifs being shared between both tissues (
22-1	4573-4577	This	abstract	giv	coref	22-6[233_0]
22-2	4578-4581	can	_	_	_	_
22-3	4582-4584	be	_	_	_	_
22-4	4585-4595	visualized	_	_	_	_
22-5	4596-4598	by	_	_	_	_
22-6	4599-4609	enrichment	abstract[233]	giv[233]	coref	26-5[252_233]
22-7	4610-4612	of	abstract[233]	giv[233]	_	_
22-8	4613-4620	similar	abstract[233]|abstract[234]	giv[233]|giv[234]	coref	22-17[238_234]
22-9	4621-4627	motifs	abstract[233]|abstract[234]	giv[233]|giv[234]	_	_
22-10	4628-4636	patterns	abstract[233]|abstract[235]	giv[233]|giv[235]	_	_
22-11	4637-4644	between	abstract[233]|abstract[235]	giv[233]|giv[235]	_	_
22-12	4645-4648	the	abstract[233]|abstract[235]|object[236]	giv[233]|giv[235]|new[236]	_	_
22-13	4649-4654	liver	abstract[233]|abstract[235]|object[236]	giv[233]|giv[235]|new[236]	_	_
22-14	4655-4658	and	abstract[233]|abstract[235]	giv[233]|giv[235]	_	_
22-15	4659-4665	spleen	abstract[233]|abstract[235]|object	giv[233]|giv[235]|new	_	_
22-16	4666-4670	with	_	_	_	_
22-17	4671-4673	25	abstract[238]	giv[238]	coref	27-5[262_238]
22-18	4674-4687	significantly	abstract[238]	giv[238]	_	_
22-19	4688-4696	enriched	abstract[238]	giv[238]	_	_
22-20	4697-4703	motifs	abstract[238]	giv[238]	_	_
22-21	4704-4709	being	_	_	_	_
22-22	4710-4716	shared	_	_	_	_
22-23	4717-4724	between	_	_	_	_
22-24	4725-4729	both	abstract[239]	giv[239]	coref	26-8[253_239]
22-25	4730-4737	tissues	abstract[239]	giv[239]	_	_
22-26	4738-4739	(	_	_	_	_

#Text=Figure 5
23-1	4740-4746	Figure	abstract[240]	giv[240]	_	_
23-2	4747-4748	5	abstract[240]	giv[240]	_	_

#Text=A ) .
24-1	4749-4750	A	_	_	_	_
24-2	4751-4752	)	_	_	_	_
24-3	4753-4754	.	_	_	_	_

#Text=These organs are expected to contain cell types or structures within the local microenvironment that have common biological functions , representing a theoretical construct for targeting to a multi-organ system .
25-1	4755-4760	These	object[241]	giv[241]	_	_
25-2	4761-4767	organs	object[241]	giv[241]	_	_
25-3	4768-4771	are	_	_	_	_
25-4	4772-4780	expected	_	_	_	_
25-5	4781-4783	to	_	_	_	_
25-6	4784-4791	contain	_	_	_	_
25-7	4792-4796	cell	object|place[243]|abstract[244]	new|giv[243]|giv[244]	_	_
25-8	4797-4802	types	place[243]|abstract[244]	giv[243]|giv[244]	_	_
25-9	4803-4805	or	abstract[244]	giv[244]	_	_
25-10	4806-4816	structures	abstract[244]|abstract	giv[244]|new	coref	26-26
25-11	4817-4823	within	_	_	_	_
25-12	4824-4827	the	abstract[246]	giv[246]	coref	26-28[258_246]
25-13	4828-4833	local	abstract[246]	giv[246]	_	_
25-14	4834-4850	microenvironment	abstract[246]	giv[246]	_	_
25-15	4851-4855	that	_	_	_	_
25-16	4856-4860	have	_	_	_	_
25-17	4861-4867	common	abstract[247]	giv[247]	_	_
25-18	4868-4878	biological	abstract[247]	giv[247]	_	_
25-19	4879-4888	functions	abstract[247]	giv[247]	_	_
25-20	4889-4890	,	_	_	_	_
25-21	4891-4903	representing	_	_	_	_
25-22	4904-4905	a	abstract[248]	new[248]	_	_
25-23	4906-4917	theoretical	abstract[248]	new[248]	_	_
25-24	4918-4927	construct	abstract[248]	new[248]	_	_
25-25	4928-4931	for	_	_	_	_
25-26	4932-4941	targeting	_	_	_	_
25-27	4942-4944	to	_	_	_	_
25-28	4945-4946	a	abstract[249]	new[249]	_	_
25-29	4947-4958	multi-organ	abstract[249]	new[249]	_	_
25-30	4959-4965	system	abstract[249]	new[249]	_	_
25-31	4966-4967	.	_	_	_	_

#Text=Finally , we demonstrated motif enrichment within single tissues , including the tumor xenograft , which suggests there are tissue-specific genes that are overexpressed or structures in the microenvironment that allow for tissue-selective accumulation of phages .
26-1	4968-4975	Finally	_	_	_	_
26-2	4976-4977	,	_	_	_	_
26-3	4978-4980	we	person	giv	_	_
26-4	4981-4993	demonstrated	_	_	_	_
26-5	4994-4999	motif	abstract|abstract[252]	giv|giv[252]	_	_
26-6	5000-5010	enrichment	abstract[252]	giv[252]	_	_
26-7	5011-5017	within	_	_	_	_
26-8	5018-5024	single	abstract[253]	giv[253]	_	_
26-9	5025-5032	tissues	abstract[253]	giv[253]	_	_
26-10	5033-5034	,	abstract[253]	giv[253]	_	_
26-11	5035-5044	including	abstract[253]	giv[253]	_	_
26-12	5045-5048	the	abstract[253]|object[255]	giv[253]|new[255]	_	_
26-13	5049-5054	tumor	abstract[253]|abstract|object[255]	giv[253]|new|new[255]	coref	27-17
26-14	5055-5064	xenograft	abstract[253]|object[255]	giv[253]|new[255]	_	_
26-15	5065-5066	,	_	_	_	_
26-16	5067-5072	which	_	_	_	_
26-17	5073-5081	suggests	_	_	_	_
26-18	5082-5087	there	_	_	_	_
26-19	5088-5091	are	_	_	_	_
26-20	5092-5107	tissue-specific	abstract[256]	giv[256]	_	_
26-21	5108-5113	genes	abstract[256]	giv[256]	_	_
26-22	5114-5118	that	_	_	_	_
26-23	5119-5122	are	_	_	_	_
26-24	5123-5136	overexpressed	_	_	_	_
26-25	5137-5139	or	_	_	_	_
26-26	5140-5150	structures	abstract	giv	_	_
26-27	5151-5153	in	_	_	_	_
26-28	5154-5157	the	abstract[258]	giv[258]	coref	27-16[265_258]
26-29	5158-5174	microenvironment	abstract[258]	giv[258]	_	_
26-30	5175-5179	that	_	_	_	_
26-31	5180-5185	allow	_	_	_	_
26-32	5186-5189	for	_	_	_	_
26-33	5190-5206	tissue-selective	abstract[259]	giv[259]	ana	27-1[0_259]
26-34	5207-5219	accumulation	abstract[259]	giv[259]	_	_
26-35	5220-5222	of	abstract[259]	giv[259]	_	_
26-36	5223-5229	phages	abstract[259]|abstract	giv[259]|giv	_	_
26-37	5230-5231	.	_	_	_	_

#Text=This is demonstrated by 3-mer motifs like “ MYW ” that are only enriched within the tumor microenvironment and suggested to play a role in selective binding of a tumor-specific marker .
27-1	5232-5236	This	abstract	giv	_	_
27-2	5237-5239	is	_	_	_	_
27-3	5240-5252	demonstrated	_	_	_	_
27-4	5253-5255	by	_	_	_	_
27-5	5256-5261	3-mer	abstract[262]	giv[262]	_	_
27-6	5262-5268	motifs	abstract[262]	giv[262]	_	_
27-7	5269-5273	like	abstract[262]	giv[262]	_	_
27-8	5274-5275	“	abstract[262]	giv[262]	_	_
27-9	5276-5279	MYW	abstract[262]|abstract	giv[262]|new	_	_
27-10	5280-5281	”	abstract[262]	giv[262]	_	_
27-11	5282-5286	that	_	_	_	_
27-12	5287-5290	are	_	_	_	_
27-13	5291-5295	only	_	_	_	_
27-14	5296-5304	enriched	_	_	_	_
27-15	5305-5311	within	_	_	_	_
27-16	5312-5315	the	abstract[265]	giv[265]	_	_
27-17	5316-5321	tumor	abstract|abstract[265]	giv|giv[265]	_	_
27-18	5322-5338	microenvironment	abstract[265]	giv[265]	_	_
27-19	5339-5342	and	_	_	_	_
27-20	5343-5352	suggested	_	_	_	_
27-21	5353-5355	to	_	_	_	_
27-22	5356-5360	play	_	_	_	_
27-23	5361-5362	a	abstract[266]	new[266]	_	_
27-24	5363-5367	role	abstract[266]	new[266]	_	_
27-25	5368-5370	in	abstract[266]	new[266]	_	_
27-26	5371-5380	selective	abstract[266]|abstract[267]	new[266]|new[267]	_	_
27-27	5381-5388	binding	abstract[266]|abstract[267]	new[266]|new[267]	_	_
27-28	5389-5391	of	abstract[266]|abstract[267]	new[266]|new[267]	_	_
27-29	5392-5393	a	abstract[266]|abstract[267]|abstract[268]	new[266]|new[267]|new[268]	_	_
27-30	5394-5408	tumor-specific	abstract[266]|abstract[267]|abstract[268]	new[266]|new[267]|new[268]	_	_
27-31	5409-5415	marker	abstract[266]|abstract[267]|abstract[268]	new[266]|new[267]|new[268]	_	_
27-32	5416-5417	.	_	_	_	_
